Key facts
- Notable investors include Michigan Rise, Biosciences Research and Commercialization Center, Penn Center for Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Coronation Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Coronation Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Coronation Bio
Developer of obesity treatments intended to help patients manage and reduce excess weight. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- East Lansing, MI, United States
- Ownership
- Privately Held (backing)
Coronation Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coronation Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coronation Bio in its N-PORT filings yet. We sweep new filings monthly.